Trial intelligence / Profile preview

Metformin PK/PD in Healthy Elderly Males

NCT02125305Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Aug 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Primary endpoint: Area Under the Plasma Concentration-Time Curve at 12 hours. Started Aug 2013; status: completed.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02125305.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02125305.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call